Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To examine the safety, tolerability and potential effectiveness of 52 weeks exposure to CPHPC (investigational product) compared to placebo for the treatment of Alzheimer’s disease.
Critère d'inclusion
- Alzheimer's disease